ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Proven technology leader to play key role at fast-growing pharmaceutical services firm
|
|||||
PRINCETON, N.J., March 14, 2016 -- APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Ms. Aparna Mazumdar has joined the firm as Head of Global Business Solutions. Aparna will lead the development and implementation of technology-based solutions for APCER’s expanding offices and rapidly growing client base.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4061d734-3a14-471e-b850-b6d3287f548f
“We are taking major steps to enhance our information technology and business solutions through significant investments in talent, processes, and assets,” said Suneet Walia, President and CEO of APCER Life Sciences, Inc. “We are pleased to welcome Aparna, a proven technology leader in the pharmaceutical industry, to play a key role in the next phase of our journey.”
Aparna has more than fifteen years’ experience in managing IT organizations and executing enterprise level projects. She worked for twelve years at Sun Pharma in positions of increasing responsibility and was most recently the Global Head of R&D IT at Sun Pharmaceutical Industries Ltd. Prior to that, Aparna worked with Pentasoft Technologies Ltd. as Project Manager & Faculty. She also has three years of research experience.
“APCER has a bold plan to develop products and services that maximize efficiencies and compliance,” said Aparna Mazumdar. “I’m excited to apply the experience I’ve gained inside a dynamic pharmaceutical company to deliver solutions that will provide benefits across the global marketplace.”
Aparna holds a Master of Life Sciences degree from DAVV Indore, a Master of Biotechnology and Engineering from India Institute of Technology Kharagpur, one of India’s most prestigious technical universities, and a Master of Business Administration with specialization in Strategic Management and Information Technology from Management Development Institute, a premier business school in Gurgaon, India.
Aparna will be based in APCER’s Delhi, India office and lead a global team located in Delhi and London, UK.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with its clients. It brings together safety, medical, regulatory, and technology resources from around the world to ensure that patients receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health, please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com; and contact APCER at one of their global offices.
Jill Notte APCER Life Sciences 609-436-4714
